Barclays upgrades 3M; more attractive 'risk/reward' basis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
RBC Capital on 3M (MMM) Post Meeting: 'management team showed good command and control of the busines'
March 20, 2024 2:48 PM EDTRBC Capital analyst Deane Dray reiterated an Underperform rating and $84.00 price target on 3M (NYSE: MMM)
The analyst comments "Underperform-rated 3M hosted a Solventum (Health Care) investor meeting on Mar-19 in NYC. Much of the presentation focused on the portfolio of businesses, opportunities to... More
3M (MMM) PT Raised to $114 at Citi
March 20, 2024 7:43 AM EDTCiti analyst Andrew Kaplowitz raised the price target on 3M (NYSE: MMM) to $114.00 (from $104.00) while maintaining a Neutral rating.
The analyst comments "Ahead of MMMs planned spinoff of its Health Care segment (Solventum) on April 1st, we are raising MMMs... More
